GUIDED THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Guided Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Guided Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $14.8K, a 86.1% decline year-over-year.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $236K, a 34.3% increase from 2022.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $176K, a 23% decline from 2021.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $228K, a 26.5% decline from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $236K +$60.3K +34.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $176K -$52.4K -23% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $228K -$82K -26.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-30
2020 $310K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.